Last reviewed · How we verify
CTH120
At a glance
| Generic name | CTH120 |
|---|---|
| Sponsor | Connecta Therapeutics, S.L. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CTH120 CI brief — competitive landscape report
- CTH120 updates RSS · CI watch RSS
- Connecta Therapeutics, S.L. portfolio CI